Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04541667 · ClinicalTrials.gov registry record · NA

Is End Tidal CO2 Level Elevation During Upper Endoscopy With CO2 Gas Insufflation Physiologically Significant

A NA study of Endoscopy, sponsored by University of Nebraska.

Completed
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT04541667 is a NA study of Endoscopy that has completed, run by University of Nebraska. The registered enrollment target is 200 participants, roughly in line with the 218-participant average among 7 other Endoscopy trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04541667, a NA study of Endoscopy, has completed, sponsored by University of Nebraska.

COMPLETED
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

During the course of an endoscopic procedure, air has historically been used to inflate the lumen to provide adequate visualization and allow for the endoscope to advance as necessary. In many adult centers, carbon dioxide is used for insufflation for all procedures. Many pediatric centers have started using carbon dioxide for insufflation during endoscopy based on the adult studies. Few pediatric studies have been done. This study is designed to test whether carbon dioxide is associated with any negative, post-procedural, outcomes in pediatric patients.

Conditions Studied

Interventions

  • OTHER Carbon Dioxide
  • OTHER Air

Study Locations (1)

Nebraska

  • Children's Hospital & Medical Center - Omaha

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2019-11-18
Est. Completion 2022-05-31
Phase NA

Sponsor

University of Nebraska

407 total trials

What the Registry Record Tells You About NCT04541667

The ClinicalTrials.gov registry entry for NCT04541667 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 218-participant average among 7 other Endoscopy trials with a reported enrollment target. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Endoscopy appearing as the primary indexed condition, and to 2 interventions - of which Carbon Dioxide is the first listed.

NCT04541667 reports 1 study location spanning 1 distinct geographic area - top geographies include Nebraska.

Frequently Asked Questions

What is clinical trial NCT04541667 about?

NCT04541667 is a clinical study titled "Is End Tidal CO2 Level Elevation During Upper Endoscopy With CO2 Gas Insufflation Physiologically Significant". During the course of an endoscopic procedure, air has historically been used to inflate the lumen to provide adequate visualization and allow for the endoscope to advance as necessary. In many adult centers, carbon dioxide is used for insufflation for all procedures. Many pediatric centers have star...

What is the current status of trial NCT04541667?

This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2019-11-18. Estimated completion is 2022-05-31.

What conditions does trial NCT04541667 study?

This clinical trial studies the following conditions: Endoscopy.

What interventions are being tested in trial NCT04541667?

The interventions under investigation include: Carbon Dioxide (OTHER), Air (OTHER).

Who is sponsoring clinical trial NCT04541667?

This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04541667 being conducted?

This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Endoscopy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.